October 24, 2019 – Data from a phase 1, open-label, multi-center safety trial of lyophilized platelets were recently presented at the 2019 AABB Annual Meeting in San Antonio, Texas. Thrombosomes® (lyophilized platelets) are prepared from a pool of apheresis-derived human platelet units, pathogen-reduced with heat sterilization, and freeze-dried in the presence of trehalose (a naturally-derived […]

July 18, 2019 – Cellphire, Inc., the global leader in long-term cell stabilization and storage of platelets and other cells, announced today that the company completed enrollment of its Phase 1 clinical trial to evaluate Thrombosomes® in bleeding, thrombocytopenic patients. Thrombosomes is a freeze-dried hemostatic agent derived from human platelets.“The success in completing enrollment in […]

May 15, 2019 – Cellphire, Inc., the global leader in long-term stabilization and storage of platelets and other cells, announced today that John B. Holcomb, M.D., F.A.C.S., will serve as Medical Consultant.Dr. Holcomb has extensive experience in the treatment of military and civilian trauma patients and has led three major trauma clinical trials in the […]

February 27, 2019 — Cellphire, Inc., the global leader in long-term stabilization and storage of platelets and other cells, announced today that the Defense Advanced Research and Development Authority (DARPA) has awarded the company a seven-figure contract in conjunction with the University of North Carolina at Chapel Hill for Research Aimed to Extend the Golden […]

May 1, 2018 — Cellphire, Inc., the global leader in long-term stabilization and storage of platelets and other cells, announced today that Keith A. Moskowitz, Ph.D. MPM, has joined the company as Vice President of Discovery.  Dr. Moskowitz has more than two decades of leadership experience directing R&D, liaison and strategy in companies with revenues […]

March 1, 2018 — Cellphire, Inc., the global leader in long-term stabilization and storage of platelets and other cells, announced today that Heather Pidcoke, MD, MSCI, Ph.D., has joined the company as Chief Medical Officer.  Dr. Pidcoke’s translational research interests include trauma critical care and novel transfusion products aimed at improving the resuscitation of massively […]

February 1, 2018 — Cellphire, Inc., the global leader in long-term stabilization and storage of platelets and other cells, announced today that the in-human care population of elephants is plagued by an endotheliotropic herpes virus that attacks young elephants and causes an acute loss of platelets with associated bleeding.  BodeVet, Inc. working with the Smithsonian […]

Cellphire, Inc. announced today that investors who participated in the $3,000,000 Cellphire funding round that closed in June have received their Final Tax Credit Certificates from the Maryland Department of Commerce awarding them a 50% refundable tax credit for their investments in Cellphire.  They are now able to claim the tax refund by filing their […]

BodeVet Chief Technical Officer, Anne Hale, CVM, will advise on controversies in blood banking at the International Veterinary Emergency and Critical Care Symposium, (IVECCS) 2017 in Nashville, Tennessee.  As a recognized world leader in veterinary blood banking, Dr. Hale joins a select panel of experts for a discussion of veterinary blood banking challenges.  This discussion […]

Thanks to a grant from the International Elephant Foundation, Cellphire, Smithsonian Global Health Program, Ringling Bros. Center for Elephant Conservation, Fort Worth Zoo and Houston Zoo have made great strides in developing a novel treatment for a lethal virus afflicting baby Asian elephants around the globe.  Elephant Endotheliotropic Herpesvirus (EEHV) is the leading cause of […]